TAK-264 (MLN0264) in previously treated Asian patients with advanced gastrointestinal carcinoma expressing guanylyl cyclase C: Results from an open-label, non-randomized phase 1 study

Bang Y.-J.Takano T.CHIA-CHI LINFasanmade A.Yang H.Danaee H.Asato T.Kalebic T.Wang H.Doi T.2022-09-152022-09-1520181598-2998https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044942194&doi=10.4143%2fcrt.2017.074&partnerID=40&md5=2672520b4a0b979d1222bcc77135d672https://scholars.lib.ntu.edu.tw/handle/123456789/620268[SDGs]SDG3TAK-264 (MLN0264) in previously treated Asian patients with advanced gastrointestinal carcinoma expressing guanylyl cyclase C: Results from an open-label, non-randomized phase 1 studyjournal article10.4143/crt.2017.074284945352-s2.0-85044942194